Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Free Report) have received an average rating of “Moderate Buy” from ...
Enlivex Therapeutics Ltd. (NASDAQ:ENLV) Short Interest Update
Enlivex Therapeutics Ltd. (NASDAQ:ENLV – Get Free Report) saw a significant decrease in short interest in the month of February. As of February 15th, there was short interest totalling 105,100 shares, ...